ArticleThe oncologist2020

Successful Treatment of Patients with Refractory High-Grade Serous Ovarian Cancer with GOPC-ROS1 Fusion Using Crizotinib: A Case Report.

Dapeng Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.